Alberico Catapano: The Role of Triglyceride Variability and the AIFA Reimbursement Gap
Alberico Catapano, Professor at Multimedica IRCCS, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Nutrition, Metabolism and Cardiovascular Diseases, adding:
“Pleased to share our latest real-world study on secondary cardiovascular prevention after acute coronary syndrome (ACS).
Despite intensive LDL-C lowering, residual cardiovascular risk remains substantial.
In our cohort of post-ACS patients, we found that:
Triglyceride variability, not absolute triglyceride levels, was independently associated with recurrent ischemic events over 12 months.
A striking gap exists between the European Medicines Agency (EMA) indication and the Italian Medicines Agency (AIFA) reimbursement criteria for icosapent ethyl (IPE): while several patients met the EMA eligibility criteria, almost none qualified for reimbursement under current AIFA rules.
These findings highlight an important opportunity to improve secondary prevention by aligning reimbursement policies with the available evidence, potentially enhancing patient outcomes while remaining cost-effective.”
Title: European Medicines Agency versus Italian Medicines Agency indications for icosapent ethyl: a long and winding road
Authors: Gavino Casu, Chiara Idini, Alberto Santoru, Giuseppe Serra, Ferruccio Bilotta, Carlo Poddighe, Pierluigi Merella, Valentina De Murtas, Federica Rubbino, Valentina Micheluzzi, Alberico L. Catapano
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 6, 2026, 10:56Moustafa Abdou: LE Cells and the Early Diagnosis of Lupus
-
Oct 6, 2026, 10:35Caitlin Raymond: Understanding IgA Deficiency and Anaphylaxis Risk
-
Oct 6, 2026, 10:15Zeeshan Ali Baig: AI-Designed Peptide for Rare Bleeding Disorder
-
Oct 6, 2026, 10:12Srivatsan Rangachari: Stem Cell Transplant for 12-Year-Old with Fanconi Anaemia
-
Oct 6, 2026, 09:56Anitha Narayanamurthy: A Possible Missing Link in Unexplained Blood Test Abnormalities
-
Oct 6, 2026, 09:46Francois Roubille: Biomarkers and Long-Term Prognosis After Revascularised STEMI
-
Oct 6, 2026, 09:20EAS Rare Lipid Disorder Course – Advancing Lipid Disorder Education – European Atherosclerosis Society
-
Oct 6, 2026, 09:12Fionnuala Ní Áinle: Lisa Ryan’s First Thrombocalc VTE Research Report
-
Oct 6, 2026, 09:02David McIntosh: Preventable Maternal and Newborn Deaths – The Urgent Need for Action